96 related articles for article (PubMed ID: 25060715)
1. Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts.
Gomez-Lira M; Ferronato S; Malerba G; Santinami M; Maurichi A; Sangalli A; Turco A; Perego P; Rodolfo M
Exp Dermatol; 2014 Oct; 23(10):766-8. PubMed ID: 25060715
[TBL] [Abstract][Full Text] [Related]
2. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
3. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.
Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F
Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].
Cao MB; Yang YX; Dong L
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):773-7. PubMed ID: 21059296
[TBL] [Abstract][Full Text] [Related]
5. Functional genetic variations of cyclooxygenase-2 and susceptibility to acute myeloid leukemia in a Chinese population.
Zheng J; Chen S; Jiang L; You Y; Wu D; Zhou Y
Eur J Haematol; 2011 Dec; 87(6):486-93. PubMed ID: 21848701
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer.
Zhang X; Zhong R; Zhang Z; Yuan J; Liu L; Wang Y; Kadlubar S; Feng F; Miao X
Mol Carcinog; 2011 Nov; 50(11):876-83. PubMed ID: 21538574
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
8. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs.
Lee YS; Kim H; Wu TX; Wang XM; Dionne RA
Clin Pharmacol Ther; 2006 May; 79(5):407-18. PubMed ID: 16678543
[TBL] [Abstract][Full Text] [Related]
9. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
[TBL] [Abstract][Full Text] [Related]
10. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
Ma SL; Tang NL; Zhang YP; Ji LD; Tam CW; Lui VW; Chiu HF; Lam LC
Neurobiol Aging; 2008 Jun; 29(6):856-60. PubMed ID: 17234302
[TBL] [Abstract][Full Text] [Related]
11. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
12. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis.
Hill MR; Papafili A; Booth H; Lawson P; Hubner M; Beynon H; Read C; Lindahl G; Marshall RP; McAnulty RJ; Laurent GJ
Am J Respir Crit Care Med; 2006 Oct; 174(8):915-22. PubMed ID: 16840740
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
[TBL] [Abstract][Full Text] [Related]
14. Association of MMP8 gene variation with an increased risk of malignant melanoma.
Dębniak T; Jakubowska A; Serrano-Fernández P; Kurzawski G; Cybulski C; Chauhan SR; Laxton RC; Maleszka R; Lubinski J; Ye S
Melanoma Res; 2011 Oct; 21(5):464-8. PubMed ID: 21642878
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.
Shan XY; Chen GZ; Cheng GP; Tao HM
J Mol Neurosci; 2013 Oct; 51(2):461-6. PubMed ID: 23852948
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 gene polymorphisms and risk of Alzheimer's disease: A meta-analysis.
Luo D; Long Y; Chen GJ
J Neurol Sci; 2015 Dec; 359(1-2):100-5. PubMed ID: 26671095
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
18. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
19. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.
Zhao D; Xu D; Zhang X; Wang L; Tan W; Guo Y; Yu D; Li H; Zhao P; Lin D
Gastroenterology; 2009 May; 136(5):1659-68. PubMed ID: 19422084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
